Homepage Top Section2

As per terms of the deal, Catalent will involve in the development of a powder-in-capsule formulation for Ennaid’s ENU200 programme. Ennaid’s ENU200 is a patent-pending and repurposed oral

In the late-stage trial called IKEMA, Sarclisa, when added to carfilzomib and dexamethasone, met the primary endpoint by delivering significantly prolonged progression-free survival compared to standard of care

In this regard, the Texas-based Acer Therapeutics has signed a research collaboration agreement with NCATS, which is one of the National Institutes of Health (NIH) in the US.

According to jCyte, treatment with jCell is a minimally-invasive intravitreal injection, which can be carried out in an ophthalmologist’s office with topical anesthetic. The entire procedure is said

Enhertu, a HER2-directed antibody drug conjugate (ADC), is being studied under a comprehensive development programme to assess the efficacy and safety of the monotherapy across multiple HER2-driven cancers

The partnership will focus on the testing of a plant produced antigens in a vaccine for Covid-19, the disease resulted due to the SARS-CoV-2 novel coronavirus VIDO-InterVac director

In March, the companies forged a collaboration to co-develop and supply potential mRNA-based coronavirus vaccines that include BNT162. The early-stage trial for the Covid-19 vaccine candidate is part of

The EUA will enable wider use of remdesivir for treating hospitalised patients with severe Covid-19 disease, enabling access to the medication at more hospitals across the US, said

The collaboration will allow to develop and distribute the university’s potential recombinant adenovirus vaccine for the prevention of COVID-19 infection from SARS-CoV-2. The potential vaccine, dubbed ChAdOx1 nCoV-19,